Lv5
841 积分 2023-06-26 加入
Measurable Residual Disease–Guided Therapy for Chronic Lymphocytic Leukemia
15小时前
已完结
Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension
15小时前
已完结
Lorundrostat in Participants With Uncontrolled Hypertension and Treatment-Resistant Hypertension
15小时前
已完结
Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension
15小时前
已完结
Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial
15小时前
已完结
Outcomes After CABG Compared With FFR-Guided PCI in Patients Presenting With Acute Coronary Syndrome
15小时前
求助中
Overall Survival with Inavolisib in PIK3CA -Mutated Advanced Breast Cancer
15小时前
已完结
Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial
1个月前
已完结
Porustobart (HBM4003) plus toripalimab as second-line therapy in patients with advanced hepatocellular carcinoma: a multicenter, open-label, phase I study
1个月前
已完结
A phase II study of neoadjuvant GVAX and cyclophosphamide combined with nivolumab and SBRT followed by surgery in borderline resectable pancreatic adenocarcinoma
1个月前
已完结
皖公网安备34019202002308
